Skip to content

Total Assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$86.48B-6.4%
Eli Lilly logo
Eli LillyLLY
$116.58B+30.4%
Johnson & Johnson logo
Johnson & JohnsonJNJ
$200.89B+3.7%
Amgen logo
AmgenAMGN
$92.5B+3.5%
AbbVie logo
AbbVieABBV
$136.46B+0.2%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$1.67B+81.7%

Other financials

Income statement

See full
Revenue-
Operating income-$36.4M-45.2%
Net income-$31.8M-51.5%
EPS (diluted)-$0.46+93.4%

Balance sheet

See full
Cash & equivalents$49.5M-40.7%
Total debt$1.8M+90.8%
Total equity$486.7M+33.4%

Cash flow

See full
Operating cash flow-$23.6M-13.0%
CapEx$73.0K+462%
Free cash flow-$23.7M-13.3%

Valuation

See full
Market cap$4.36B+533%
Enterprise value$4.32B+690%

Returns & leverage

See full
Return on equity-27.3%-11.1pp
Debt / equity0.0×
Current ratio23.8×-6.3×

Where this comes from

Reported directly by Oruka Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oruka Therapeutics, Inc.'s total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oruka Therapeutics, Inc.'s total assets?
Oruka Therapeutics, Inc. (ORKA) reported total assets of $504.48M in Q1 2026.
How has Oruka Therapeutics, Inc.'s total assets changed year-over-year?
Oruka Therapeutics, Inc.'s total assets increased by 33.8% year-over-year, from $377.11M to $504.48M.
What is the long-term trend for Oruka Therapeutics, Inc.'s total assets?
Over 5 years (2020 to 2025), Oruka Therapeutics, Inc.'s total assets has grown at a 57.5% compound annual growth rate (CAGR), from $50.43M to $488.62M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.